尿表皮生长因子排泄与肾功能快速丢失
在挪威RENIS(N=1249)和荷兰PREVEND(N=4534)两个普通人群队列中,中位随访5.6年和7.4年,发现基线尿表皮生长因子(uEGF)排泄较低与肾功能快速下降及新发慢性肾脏病(CKD)风险增加相关,提示uEGF可作为反映肾小管成分的广泛适用生物标志物。
要点
- 普通人群中较低uEGF排泄与快速GFR下降独立相关。
- 较低uEGF水平与新发CKD风险增加相关。
- uEGF可能补充以肾小球为中心的临床风险评估体系。
核心结论
- 普通人群中较低uEGF水平与肾功能快速丢失和新发CKD风险增加相关。
研究设计与样本
- 从挪威普通人群招募无CKD或糖尿病的受试者(RENIS,N=1249),中位随访5.6年。
- 从荷兰普通人群招募无CKD或糖尿病的受试者(PREVEND,N=4534),中位随访7.4年。
- RENIS用碘海醇清除率测量GFR,PREVEND用CKD-EPI肌酐-胱抑素C方程估算GFR。
- 快速GFR下降定义为年GFR丢失>3.0 mL/min/1.73 m2,敏感性分析为各队列中GFR斜率最陡的10%受试者。
主要发现
- RENIS中,uEGF每低1 μg/mmol,快速GFR下降的比值比(OR)为1.42(95%CI 1.06-1.91),P=0.02,校正基线GFR、白蛋白肌酐比和传统CKD危险因素。
- PREVEND中,uEGF每低1 μg/mmol,快速GFR下降的OR为1.29(95%CI 1.10-1.53),P<0.01,校正同上。
- 使用各队列GFR斜率最陡的10%作为结局,结果相似。
- 两队列联合分析中,较低uEGF水平与新发CKD相关。
临床怎么用
- 在普通人群中,uEGF可能作为反映肾小管损伤的生物标志物,辅助识别肾功能快速下降高风险个体。
- uEGF有望补充当前以肾小球为中心的临床风险评估体系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower urinary excretion of the kidney tubule-specific biomarker epidermal growth factor (uEGF) is associated with increased risk of renal function [glomerular filtration rate (GFR)] loss in diabetes and in patients with established chronic kidney disease (CKD). We investigated whether uEGF is associated with rapid GFR decline or incident CKD in the general population. METHODS: Subjects without CKD or diabetes were recruited from the general population in Tromso, Norway [Renal Iohexol Clearance Survey (RENIS); N = 1249] and Groningen, the Netherlands [Prevention of REnal and Vascular END-stage disease (PREVEND); N = 4534], with a median follow-up of 5.6 and 7.4 years, respectively. GFR was measured by iohexol clearance in the RENIS and estimated using the CKD Epidemiology Collaboration creatinine-cystatin C equation in the PREVEND study. Rapid GFR decline was defined as an annual GFR loss >3.0 mL/min/1.73 m2 and in sensitivity analyses as subjects with the 10% steepest GFR slope within each cohort. RESULTS: Lower baseline uEGF excretion was associated with rapid GFR loss in both cohorts {RENIS, odds ratio [OR] per 1 μg/mmol lower uEGF 1.42 [95% confidence interval (CI) 1.06-1.91], P = 0.02; PREVEND, OR 1.29 [95% CI 1.10-1.53], P < 0.01}, adjusted for baseline GFR, albumin:creatinine ratio and conventional CKD risk factors. Similar results were obtained using the outcome of the 10% steepest GFR slope in each cohort. Lower uEGF levels were associated with incident CKD in the combined analysis of both cohorts. CONCLUSIONS: Lower uEGF levels are associated with increased risk of rapid GFR loss and incident CKD in the general population. This finding, together with previous findings in CKD and high-risk populations, supports that uEGF may serve as a broadly applicable biomarker representing the tubular component of the current glomerulus-centric clinical risk assessment system.
引用
- Norvik JV, Harskamp LR, Nair V, et al. Urinary excretion of epidermal growth factor and rapid loss of kidney function. Nephrol Dial Transplant. 2021. PMID: 33068410. doi:10.1093/ndt/gfaa208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。